-+ 0.00%
-+ 0.00%
-+ 0.00%

Metagenomi Therapeutics: Q3 Earnings Snapshot

Barchart·11/10/2026 16:14:54
Listen to the news

EMERYVILLE, Calif. (AP) — EMERYVILLE, Calif. (AP) — Metagenomi Therapeutics, Inc. (MGX) on Tuesday reported a loss of $21.1 million in its third quarter.

On a per-share basis, the Emeryville, California-based company said it had a loss of 56 cents.

The genetic medicines company posted revenue of $2.2 million in the period.

_____

This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on MGX at https://www.zacks.com/ap/MGX